Prelude gets FDA OK for early stage trial of cancer treatment candidate

Delaware Business Now

Oct 22, 2022

Prelude Therapeutics Incorporated announced that the U.S. Food and Drug Administration (FDA) cleared the company to proceed with a Phase 1 study under its Investigational New Drug…